Bausch Health Companies (BHC) Price to Sales (2009 - 2026)

Bausch Health Companies has disclosed Price to Sales across 18 years of filings, most recently posting 0.65 for Q2 2026.

• In Q2 2026, Price to Sales fell 33.6% year-over-year to 0.65; the TTM figure through Jun 2026 stood at 0.17 (down 32.01% YoY), while the FY2025 annual figure was 0.25, down 18.56% from the prior year.
• Price to Sales came in at 0.65 for Q2 2026 at Bausch Health Companies, down from 0.8 in the prior quarter.
• In the past five years, Price to Sales ranged from a high of 4.3 in Q1 2022 to a low of 0.65 in Q2 2026.
• Average Price to Sales over 5 years is 1.33, with a median of 1.18 recorded in 2024.
• Year-over-year, Price to Sales plunged 77.07% in 2022 and grew 19.27% in 2024.
• Over 5 years, Price to Sales stood at 1.04 in 2022, then gained by 17.38% to 1.22 in 2023, then dropped by 4.76% to 1.16 in 2024, then slipped by 20.5% to 0.92 in 2025, then slipped by 29.83% to 0.65 in 2026.
• Per Business Quant data, the three most recent Price to Sales figures were 0.65 in Q2 2026, 0.8 in Q1 2026, and 0.92 in Q4 2025.